共 154 条
[1]
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]
Soerjomataram I(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[3]
Dikshit R(2013)Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery BMC Cancer 13 200-17
[4]
Eser S(2015)Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy Mol Immunol 67 4-979
[5]
Mathers C(2009)Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma Clin Cancer Res 15 971-2028
[6]
Rebelo M(2015)Pembrolizumab for the treatment of non-small-cell lung cancer N Engl J Med 372 2018-2454
[7]
Sauer R(2012)Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N Engl J Med 366 2443-800
[8]
Becker H(2002)Tumor-associated B7-H1 promotes T‑cell apoptosis: a potential mechanism of immune evasion Nat Med 8 793-1034
[9]
Hohenberger W(2000)Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J Exp Med 192 1027-264
[10]
Rodel C(2012)The blockade of immune checkpoints in cancer immunotherapy Nat Rev Cancer 12 252-325